A rapid and sensitive LC-ESI-MS/MS method for determining vincristine in micro-volumes of plasma for pediatric cancer patients
- 30 January 2023
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 15 (9) , 1178-1187
Abstract
Vincristine is a natural vinca alkaloid drug, which is widely used in pediatric cancer treatment with dose-dependent neurotoxicity. Thus far, little is known about the association between neurotoxicity and plasma vincristine concentration, which markedly varies among individuals. Routine therapeutic drug monitoring (TDM) can be seen as a reliable strategy to improve efficacy and reduce side effects. Therefore, a rapid, sensitive, and reproducible method is critical for the clinical implementation of TDM. In this study, micro-volume (50 μL) human plasma samples were prepared by a simple one-step protein precipitation method with acetonitrile. Chromatographic separation of vincristine and its internal standard vincristine-d3 from background noise was achieved on a Kinetex C18 column (2.1 mm × 50 mm, 1.7 μm) with a gradient elution program at a flow rate of 0.3 mL min−1 in 4 min. The mass spectrometric detection was performed in electrospray ionization multiple reaction monitoring mode using the ion transitions of 825.4 → 765.1 for vincristine, and 828.2 → 768.2 for vincristine-d3, respectively. As a result, no matrix effect was observed. The lower limit of quantification was 0.5 ng mL−1 with a precision of 14.6% and an accuracy of 97.4%. The calibration curve was linear from 0.5 to 100 ng mL−1 (r2 > 0.99, n = 8). The intra- and inter-batch precision and accuracy, recovery, and stability of the new method were all within the acceptable criteria. The method was successfully applied to monitor the vincristine concentration for six pediatric cancer patients. Arguably, such proactive TDM of vincristine may be helpful to manage the treatment for these cancer patients.Keywords
Funding Information
- Jiangsu Commission of Health (2019)
- Nanjing Medical University (2020)
This publication has 22 references indexed in Scilit:
- Association of an Inherited Genetic Variant With Vincristine-Related Peripheral Neuropathy in Children With Acute Lymphoblastic LeukemiaJAMA, 2015
- Strategies for Improving the Quantitative Bioanalytical Performance of LC-MS in Pharmacokinetic StudiesCurrent Drug Metabolism, 2012
- Pharmacokinetic characteristics of vincristine sulfate liposomes in patients with advanced solid tumorsActa Pharmacologica Sinica, 2012
- Validation of an electrospray ionization LC/MS/MS method for quantitative analysis of vincristine in human plasma samplesJournal of Chromatography B, 2010
- Quantification of Vincristine and its Major Metabolite in Human Plasma by High-Performance Liquid Chromatography/Tandem Mass SpectrometryTherapeutic Drug Monitoring, 2008
- Fast analysis in liquid chromatography using small particle size and high pressureJournal of Separation Science, 2006
- Determination of vincristine in infant plasma by liquid chromatography-atmospheric pressure chemical ionization-mass spectroscopyJournal of Pharmaceutical and Biomedical Analysis, 2006
- A liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of actinomycin-D and vincristine in children with cancerCancer Chemotherapy and Pharmacology, 2005
- Validation of a high-performance liquid chromatographic assay method for quantification of total vincristine sulfate in human plasma following administration of vincristine sulfate liposome injectionJournal of Pharmaceutical and Biomedical Analysis, 1997
- The comparative clinical pharmacology and pharmacokinetics of vindesine, vincristine, and vinblastine in human patients with cancerMedical and Pediatric Oncology, 1982